{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:41:47Z","timestamp":1793421707333,"version":"4.5.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Accumulating evidence suggests amyloid and tau-related neurodegeneration may play a role in development of late-onset epilepsy of unknown etiology (LOEU). In this article, we review recent evidence that epilepsy may be an initial manifestation of an amyloidopathy or tauopathy that precedes development of Alzheimer\u2019s disease (AD). Patients with LOEU demonstrate an increased risk of cognitive decline, and patients with AD have increased prevalence of preceding epilepsy. Moreover, investigations of LOEU that use CSF biomarkers and imaging techniques have identified preclinical neurodegeneration with evidence of amyloid and tau deposition. Overall, findings to date suggest a relationship between acquired, non-lesional late-onset epilepsy and amyloid and tau-related neurodegeneration, which supports that preclinical or prodromal AD is a distinct etiology of late-onset epilepsy. We propose criteria for assessing elevated risk of developing dementia in patients with late-onset epilepsy utilizing clinical features, available imaging techniques, and biomarker measurements. Further research is needed to validate these criteria and assess optimal treatment strategies for patients with probable epileptic preclinical AD and epileptic prodromal AD.<\/jats:p>","DOI":"10.3389\/fneur.2023.1241638","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:28:59Z","timestamp":1695878939000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology"],"prefix":"10.3389","volume":"14","author":[{"given":"L. Brian","family":"Hickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H. S.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Vossel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935\u20131984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S1474-4422(09)70240-6","article-title":"Epilepsy in later life","volume":"8","author":"Brodie","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1528-1157.1986.tb03567.x","article-title":"Etiology of seizures in the elderly","volume":"27","author":"L\u00fchdorf","year":"1986","journal-title":"Epilepsia"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1111\/j.1528-1167.2011.03320.x","article-title":"Newly diagnosed epileptic seizures: focus on an elderly population on the French island of R\u00e9union in the Southern Indian Ocean","volume":"52","author":"Tchalla","year":"2011","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.yebeh.2012.11.041","article-title":"Outcome of newly-diagnosed epilepsy in older patients","volume":"27","author":"Besocke","year":"2013","journal-title":"Epilepsy Behav"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neurobiolaging.2016.08.025","article-title":"Epilepsy, amyloid-\u03b2, and D1 dopamine receptors: a possible pathogenetic link?","volume":"48","author":"Costa","year":"2016","journal-title":"Neurobiol Aging"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1755-5949.2011.00251.x","article-title":"Seizures and epilepsy in Alzheimer\u2019s disease","volume":"18","author":"Friedman","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1073\/pnas.1206171109","article-title":"Critical role of soluble amyloid-\u03b2 for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease","volume":"109","author":"Busche","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1021\/acschemneuro.9b00460","article-title":"Tau related pathways as a connecting link between epilepsy and Alzheimer\u2019s disease","volume":"10","author":"Paudel","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","article-title":"Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy","volume":"29","author":"Minkeviciene","year":"2009","journal-title":"J Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1523\/JNEUROSCI.5171-13.2014","article-title":"Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzeimer\u2019s disease","volume":"34","author":"Born","year":"2014","journal-title":"J Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","article-title":"Antisense reduction of tau in adult mice protects against seizures","volume":"33","author":"DeVos","year":"2013","journal-title":"J Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","article-title":"Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease","volume":"29","author":"Bellaver","year":"2023","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.brainresrev.2009.10.004","article-title":"Astrocyte dysfunction in epilepsy","volume":"63","author":"Seifert","year":"2010","journal-title":"Brain Res Rev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e58744","DOI":"10.7554\/eLife.58744","article-title":"Seizures are a druggable mechanistic link between TBI and subsequent tauopathy","volume":"10","author":"Alyenbaawi","year":"2021","journal-title":"elife"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"903973","DOI":"10.3389\/fnagi.2022.903973","article-title":"Tauopathy and epilepsy comorbidities and underlying mechanisms","volume":"14","author":"Hwang","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.clinph.2020.08.014","article-title":"The neurophysiology and seizure outcomes of late onset unexplained epilepsy","volume":"131","author":"Sarkis","year":"2020","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jns.2018.09.010","article-title":"Incidence of dementia in patients with adult-onset epilepsy of unknown causes","volume":"395","author":"Kawakami","year":"2018","journal-title":"J Neurol Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.nicl.2015.07.016","article-title":"Structural and physiological MRI correlates of occult cerebrovascular disease in late-onset epilepsy","volume":"9","author":"Hanby","year":"2015","journal-title":"NeuroImage Clin"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1212\/WNL.0000000000001487","article-title":"Evidence-based guideline: management of an unprovoked first seizure in adults: report of the guideline development subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"84","author":"Krumholz","year":"2015","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.25421","article-title":"Development of the clinical assessment scale in autoimmune encephalitis","volume":"85","author":"Lim","year":"2019","journal-title":"Ann Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/epi.15612","article-title":"Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force","volume":"60","author":"Bernasconi","year":"2019","journal-title":"Epilepsia"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11910-008-0057-3","article-title":"Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues","volume":"8","author":"Zarow","year":"2008","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1528-1157.1992.tb02278.x","article-title":"Hippocampal pyramidal cell loss in human status epilepticus","volume":"33","author":"DeGiorgio","year":"1992","journal-title":"Epilepsia"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"106592","DOI":"10.1016\/j.yebeh.2019.106592","article-title":"Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: a 12-month follow-up study","volume":"101","author":"Liguori","year":"2019","journal-title":"Epilepsy Behav EB."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/brain\/awaa397","article-title":"Atrophy and cognitive profiles in older adults with temporal lobe epilepsy are similar to mild cognitive impairment","volume":"144","author":"Kaestner","year":"2021","journal-title":"Brain J Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3233\/JAD-150096","article-title":"Epileptic prodromal Alzheimer\u2019s disease, a retrospective study of 13 new cases: expanding the spectrum of Alzheimer\u2019s disease to an epileptic variant?","volume":"52","author":"Cretin","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2018.09.006","article-title":"Alzheimer\u2019s disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology","volume":"73","author":"Costa","year":"2019","journal-title":"Neurobiol Aging"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1111\/ejn.15734","article-title":"Cognitive functioning, cerebrospinal fluid Alzheimer\u2019s disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: a prospective study","volume":"56","author":"Fernandes","year":"2022","journal-title":"Eur J Neurosci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fneur.2020.00199","article-title":"Late-onset epilepsy with unknown etiology: a pilot study on neuropsychological profile, cerebrospinal fluid biomarkers, and quantitative EEG characteristics","volume":"11","author":"Nardi Cesarini","year":"2020","journal-title":"Front Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jocn.2021.01.030","article-title":"Ten year cumulative incidence of dementia after late onset epilepsy of unknown etiology","volume":"86","author":"Ophir","year":"2021","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000117218","article-title":"Clinical features and mortality in patients with early-onset Alzheimer\u2019s disease","volume":"36","author":"Samson","year":"1996","journal-title":"Eur Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3233\/JAD-170392","article-title":"Adult-onset epilepsy in presymptomatic Alzheimer\u2019s disease: a retrospective study","volume":"60","author":"DiFrancesco","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1176\/appi.neuropsych.15060143","article-title":"Clinical and neurophysiologic characteristics of unprovoked seizures in patients diagnosed with dementia","volume":"28","author":"Sarkis","year":"2016","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/s1092852900016151","article-title":"Mild cognitive impairment: an overview","volume":"13","author":"Petersen","year":"2008","journal-title":"CNS Spectr"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamaneurol.2020.0187","article-title":"Association of late-onset unprovoked seizures of unknown etiology with the risk of developing dementia in older veterans","volume":"77","author":"Keret","year":"2020","journal-title":"JAMA Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e3248","DOI":"10.1212\/WNL.0000000000011080","article-title":"Dementia in late-onset epilepsy: the atherosclerosis risk in communities study","volume":"95","author":"Johnson","year":"2020","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"107634","DOI":"10.1016\/j.yebeh.2020.107634","article-title":"Late-onset epilepsy predicts stroke: systematic review and meta-analysis","volume":"115","author":"Wall","year":"2021","journal-title":"Epilepsy Behav"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2018.1935","article-title":"Association between midlife risk factors and late-onset epilepsy: results from the atherosclerosis risk in communities study","volume":"75","author":"Johnson","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s40520-022-02118-8","article-title":"Late-onset epilepsy and the risk of dementia: a systematic review and meta-analysis","volume":"34","author":"Huang","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awy022","article-title":"Cognition and dementia in older patients with epilepsy","volume":"141","author":"Sen","year":"2018","journal-title":"Brain J Neurol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jamaneurol.2016.6091","article-title":"Association between childhood-onset epilepsy and amyloid burden 5 decades later","volume":"74","author":"Joutsa","year":"2017","journal-title":"JAMA Neurol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1046\/j.1528-1157.2002.18701.x","article-title":"Morbidity and accidents in patients with epilepsy: results of a European cohort study","volume":"43","author":"Beghi","year":"2002","journal-title":"Epilepsia"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/WCO.0000000000000802","article-title":"Epilepsy, antiepileptic drugs and dementia","volume":"33","author":"Beghi","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1528-1157.44.s4.3.x","article-title":"Newer antiepileptic drugs and cognitive issues","volume":"44","author":"Aldenkamp","year":"2003","journal-title":"Epilepsia"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.yebeh.2007.12.015","article-title":"The impact of epilepsy surgery on cognition and behavior","volume":"12","author":"Baxendale","year":"2008","journal-title":"Epilepsy Behav"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/oxfordjournals.aje.a117597","article-title":"Risk of dementia in patients with Parkinson\u2019s disease, epilepsy, and severe head trauma: a register-based follow-up study","volume":"142","author":"Breteler","year":"1995","journal-title":"Am J Epidemiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e399","DOI":"10.1212\/WNL.0000000000207423","article-title":"Alzheimer disease and epilepsy: a Mendelian randomization study","volume":"101","author":"Fang","year":"2023","journal-title":"Neurology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J Intern Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jocn.2022.05.003","article-title":"Non-lesional late-onset epilepsy in the elderly Japanese patients: presenting characteristics and seizure outcomes with regard to comorbid dementia","volume":"103","author":"Nagino","year":"2022","journal-title":"J Clin Neurosci"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e988","DOI":"10.1212\/WNL.0000000000007010","article-title":"Association between white matter hyperintensities, cortical volumes, and late-onset epilepsy","volume":"92","author":"Johnson","year":"2019","journal-title":"Neurology"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"107839","DOI":"10.1016\/j.yebeh.2021.107839","article-title":"Temporal lobe dysfunction in late-onset epilepsy of unknown origin","volume":"117","author":"DiFrancesco","year":"2021","journal-title":"Epilepsy Behav"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"153331752311600","DOI":"10.1177\/15333175231160005","article-title":"Utility of amyloid positron emission tomography imaging in older adults with epilepsy and cognitive decline","volume":"38","author":"Sarkis","year":"2023","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/BF00294177","article-title":"Senile plaques in temporal lobe epilepsy","volume":"87","author":"Mackenzie","year":"1994","journal-title":"Acta Neuropathol (Berl)."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1046\/j.1471-4159.1994.63051872.x","article-title":"Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity","volume":"63","author":"Sheng","year":"1994","journal-title":"J Neurochem"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/brain\/aww187","article-title":"Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections","volume":"139","author":"Tai","year":"2016","journal-title":"Brain J Neurol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1093\/brain\/awr209","article-title":"Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study","volume":"134","author":"Thom","year":"2011","journal-title":"Brain J Neurol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","article-title":"Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later","volume":"80","author":"Roe","year":"2013","journal-title":"Neurology"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/joim.12199","article-title":"Harmonized diagnostic criteria for Alzheimer\u2019s disease: recommendations","volume":"275","author":"Morris","year":"2014","journal-title":"J Intern Med"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41582-021-00505-9","article-title":"Amyloid-\u03b2: a potential link between epilepsy and cognitive decline","volume":"17","author":"Romoli","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer\u2019s disease","volume":"26","author":"Barth\u00e9lemy","year":"2020","journal-title":"Nat Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1002\/alz.12974","article-title":"Placental growth factor as a sensitive biomarker for vascular cognitive impairment","volume":"19","author":"Hinman","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.274","article-title":"CSF A\u03b242\/A\u03b240 and A\u03b242\/A\u03b238 ratios: better diagnostic markers of Alzheimer disease","volume":"3","author":"Janelidze","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1111\/epi.17132","article-title":"Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus","volume":"63","author":"Giovannini","year":"2022","journal-title":"Epilepsia"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/epi.16742","article-title":"Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug-resistant epilepsy","volume":"62","author":"Ou\u00e9draogo","year":"2021","journal-title":"Epilepsia"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat Med"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/epi.17489","article-title":"Epilepsy in cerebral amyloid angiopathy: an observational retrospective study of a large population","volume":"64","author":"Tabaee Damavandi","year":"2023","journal-title":"Epilepsia"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"111434","DOI":"10.1016\/j.mad.2021.111434","article-title":"Sleep disorders and late-onset epilepsy of unknown origin: understanding new trajectories to brain amyloidopathy","volume":"194","author":"Liguori","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/JAD-161002","article-title":"What is the relationship of traumatic brain injury to dementia?","volume":"57","author":"Mendez","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/CPJ.0000000000200098","article-title":"Self-reported severity and causes of traumatic brain injury in patients with epileptic or functional seizures","volume":"12","author":"Hickman","year":"2022","journal-title":"Neurol Clin Pract"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"eaaw8954","DOI":"10.1126\/scitranslmed.aaw8954","article-title":"Paroxysmal slow cortical activity in Alzheimer\u2019s disease and epilepsy is associated with blood-brain barrier dysfunction","volume":"11","author":"Milikovsky","year":"2019","journal-title":"Sci Transl Med"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: Appropriate Use Recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e2313239","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.seizure.2015.03.013","article-title":"Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: an extended follow-up","volume":"29","author":"Javed","year":"2015","journal-title":"Seizure"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","article-title":"Chronic divalproex sodium use and brain atrophy in Alzheimer disease","volume":"77","author":"Fleisher","year":"2011","journal-title":"Neurology"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity: a randomized clinical trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/epi4.12475","article-title":"FDA safety warning on the cardiac effects of lamotrigine: an advisory from the Ad Hoc ILAE\/AES Task Force","volume":"6","author":"French","year":"2021","journal-title":"Epilepsia Open"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1241638\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:29:03Z","timestamp":1695878943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1241638\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":88,"alternative-id":["10.3389\/fneur.2023.1241638"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1241638","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"article-number":"1241638"}}